news aktuell GmbH

nal von minden: Did my vaccine work? New rapid test for the determination of vaccination success.

Share
Am I really protected against the coronavirus now? This is a question asked by many after receiving a vaccination. The medtech company nal von minden from Moers in Germany has now developed a rapid test that can reliably detect antibodies against COVID-19 pathogens in blood. The NADAL® COVID-19 S1-NAb Test is now available all over Europe.

(Moers, Germany): “People want clarity once they been vaccinated against coronavirus: They want to know if it has worked“ says Thomas Zander, CEO of nal von minden GmbH. Depending on the particular vaccine used, the COVID-19 vaccines offer 70% or more protection from the disease – but not 100%.


If the vaccine has ‘worked’, the body produces human antibodies against the disease. “These antibodies ensure that, in the event of exposure, the disease pathogens – the coronaviruses – would be readily identified and quickly repelled. Rather like the police on alert.”

These antibodies can be found in human blood and, if present, are easily detectable. With the NADAL® COVID-19 S1-NAb Test, the process takes just a few minutes. Thomas Zander explains: “Our new rapid test for the detection of coronavirus antibodies can be carried out by your GP in the future, as the test is currently only for professional use. A tiny prick of the finger is enough. The little drop of blood is added to the accompanying test cassette, and results can be read within 15 minutes.”

The new rapid test has already been comprehensively studied in the USA and China. “In the USA and China the vaccination programmes are more progressed, so the first studies were carried out there,” says Zander. “Further quality studies at German research centres will follow shortly.” It has been confirmed that the antibody test works for all kinds of vaccines (BioNtech, AstraZeneca, Johnson&Johnson, Sinovac and Moderna).

Coronavirus vaccinations usually take place across two appointments, and the new rapid test can be carried out either two weeks after the first vaccination, or two weeks after the second, says Thomas Zander. “Those who produce an immune response following the first vaccine – which can cause, for example, mild cold-like symptoms – can first wait until after the second vaccination.” Of course, the test can also be carried out weeks or even months afterwards, as nobody yet knows how long the vaccinations protect us against coronaviruses.

Contacts

Gabriele Hellwig, info@hellwig-pr.de

Images

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Hessian Minister President Boris Rhein presents the Broermann Medical Innovation Award18.11.2025 16:00:00 CET | Press release

Dr. Carl June and Dr. Michel Sadelain honored for groundbreaking CAR-T cell research in cancer therapy One of the world’s most highly endowed medical prizes, with €1 million in prize money, awarded for the first time Titia große Broermann: “With the Broermann Medical Innovation Award, we want to make outstanding medical achievements visible – and honor those who, with courage, vision, and humanity, are shaping the medicine of tomorrow.”

SKYLOTEC announces planned integration of LIBERVIT SAS to expand tactical access solutions18.11.2025 14:38:44 CET | Press release

Neuwied, 18 November 2025 – SKYLOTEC, a global leader in fall protection, rescue equipment, and tactical access solutions, has reached an agreement to integrate the French company LIBERVIT SAS. Through this planned integration, SKYLOTEC will expand its portfolio to include hydraulic breaching tools for Military, Law Enforcement, Fire & Rescue and industrial applications. This step continues the company’s growth strategy in the LEAF segment (Law Enforcement and Armed Forces) and reinforces its position as a World Leader in Tactical Access.

ELATEC Introduces DevPack 5.07: A Major Leap Forward in RFID Reader Management and Mobile Integration18.11.2025 11:07:07 CET | Press release

(Puchheim, Germany) ELATEC, a leading manufacturer of access technologies, specializing in RFID readers and credentials, has released its latest software development toolkit, TWN4 DevPack 5.07. The new version delivers faster performance, stronger security and greater flexibility for configuring and managing RFID readers, enabling flexible and future-proof access solutions. “With every DevPack release, our goal is to make life easier for developers, system integrators and end users,” said Tobias Rasche, Global Head of Product Management of ELATEC GmbH. “Version 5.07 takes another big step forward by combining deeper diagnostics, broader mobile credential support and open-standard interoperability, all in one powerful package. With this evolution, our DevPack is now more than a development toolkit—it’s a comprehensive framework for building secure, flexible, and future-ready authentication solutions.” Future-Proof Mobile and Security Capabilities DevPack 5.07 expands ELATEC’s support fo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye